<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DD567D99-893B-43CA-B141-0C6A3D481748"><gtr:id>DD567D99-893B-43CA-B141-0C6A3D481748</gtr:id><gtr:name>School of Medicine</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DD567D99-893B-43CA-B141-0C6A3D481748"><gtr:id>DD567D99-893B-43CA-B141-0C6A3D481748</gtr:id><gtr:name>School of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6DFD53AF-4A0A-4F79-93D8-FDC0D24F2896"><gtr:id>6DFD53AF-4A0A-4F79-93D8-FDC0D24F2896</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>George</gtr:otherNames><gtr:surname>Brickley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/713039D9-A6D6-40E0-88B1-32C5AAA4EC4B"><gtr:id>713039D9-A6D6-40E0-88B1-32C5AAA4EC4B</gtr:id><gtr:firstName>William</gtr:firstName><gtr:surname>Wisden</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/86169B71-928C-4C0C-8949-92A6D5E70161"><gtr:id>86169B71-928C-4C0C-8949-92A6D5E70161</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:surname>Franks</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0901892"><gtr:id>10D1CD6B-E1CA-4ADB-A9FF-D2138D790FD5</gtr:id><gtr:title>Neuronal Pathways of Sleep and Anaesthesia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901892</gtr:grantReference><gtr:abstractText>Modern surgery would be impossible without general anaesthetics, yet the underlying mechanisms by which these chemicals produce unconsciousness and pain relief are only now being discovered. In parallel with these insights about anaesthetic action, neuroscientists have identified some of the mechanisms that control and regulate natural sleep and consciousness. The aim of our Programme of research is to bring these aspects together so as to better understand how general anaesthetics and sedative drugs act in the brain. We hope to build upon the great advances that have been made over recent years in identifying the protein targets for some of these drugs and use this specificity to guide us towards pinpointing the neuronal pathways important for their actions. The drugs currently used to anaesthetise and sedate patients are far from perfect, providing a mix of desirable (such as loss of consciousness) and undesirable (such as respiratory depression) effects. Different anaesthetics and sedative drugs act on different pathways. Working out which pathways are responsible may help us develop better drugs with fewer side-effects. The dangers of current anaesthetics, and the absence of effective remedies for insomnia, are sadly illustrated by the death of the singer Michael Jackson following the inappropriate administration of the general anaesthetic propofol. However, even in the controlled environment of a hospital, many patients suffer from undesirable side-effects caused by the anaesthetic and analgesic drugs used during perioperative care. Serious risks can be provoked in already compromised patients, a considerable concern in our ageing population. Our work on anaesthetic action tackles a major intellectual problem in basic neuroscience, and at the same time, researching anaesthetic mechanisms and natural sleep pathways, and how they are related, can be expected to provide important information that has practical applications. For example, our work should provide insights into how natural sleep pathways work, information that is likely to aid in the treatment of sleep disorders, which are increasingly common in society.</gtr:abstractText><gtr:technicalSummary>Every year, 230 million patients worldwide are given general anaesthetics, drugs that remove our most precious human attribute ? consciousness. The induction of safe and reversible loss of consciousness is a pillar of modern medicine. It also poses one of the most long-standing puzzles in neuroscience. Anaesthesia is a routine procedure, but we do not really understand how it works. Although it is clear that general anaesthetics act at a relatively small number of targets, finding the links between these receptors and anaesthetic-induced loss of consciousness presents a fascinating and important challenge. In this Programme Grant application, we propose to test and elaborate our hypothesis that anaesthetics exert their sedative/hypnotic effects by recruiting natural sleep pathways. We will combine mouse genetics, electrophysiology, and synthetic chemistry to identify the neuronal pathways that underlie the actions of anaesthetics and sedative drugs whose molecular targets have been established. By exploiting what is known at the molecular level, our research should provide insights into both how natural sleep is regulated, as well as how anaesthetics act at the level of neuronal networks. This should inform strategies for the development of new drugs, including those to treat sleep disorders. 

The Programme has five related projects:

In Project 1 we will measure cortical EEG changes simultaneously with changes in the local field potentials of selected thalamic nuclei during anaesthetic-induced loss of consciousness. This will provide fundamental reference data on thalamocortical connectivity in normal animals; these experiments will be repeated for the novel mice we plan to construct, in which known targets are either deleted, or made anaesthetic-insensitive. In Project 2 we will test the hypothesis that anaesthetics such as propofol exert their major effects by acting directly on GABA-A receptors on thalamic neurons. In Project 3 we will pursue an important recent discovery that the sedative/hypnotic agent dexmedetomidine (DEX) does not, as previously thought, act on adrenergic neurons. We will exploit the highly restricted expression of alpha2A-adrenergic receptors, the target for dexmedetomidine?s sedative actions, to test the idea that this drug acts at specific cortical sites. In Project 4, we will develop some exciting new findings of our own that point to an important role for TASK-3 potassium channels in anaesthesia, and we will test the hypothesis that their high cortical expression is responsible. In Project 5 we will investigate the mechanisms by which the hypothalamic tuberomammillary nucleus is inhibited during both anaesthesia and natural sleep.</gtr:technicalSummary><gtr:fund><gtr:end>2015-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1521862</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Anesthesiology</gtr:department><gtr:description>Collaboration on photolabelling</gtr:description><gtr:id>70FA8AE3-183F-4E0C-A555-E3ACCAD1D5C7</gtr:id><gtr:impact>A joint publication in the journal Nature Chemical Biology</gtr:impact><gtr:partnerContribution>Our partners at Washington University St. Louis labelled GABA receptors and purified the labelled peptide</gtr:partnerContribution><gtr:piContribution>We synthesised anaesthetic photolabels and tested these on animals, GABA receptors and in photolabelling human serum albumin</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kick-Start Grant</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>853B9AD0-BBE8-47FC-B658-57518F2CB387</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K018159/1</gtr:fundingRef><gtr:id>6CA29B60-3848-4445-813F-39D3B2C07C19</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>320764</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>0659C6F1-0D4E-47AA-BB4A-A392C8E376ED</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>73110</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Institute of Academic Anaesthesia studentship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>National Institute of Academic Anaesthesia</gtr:fundingOrg><gtr:id>CCD0E652-CD85-4DE8-A0F3-E1FC0988B2D4</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Neuroprotexeon</gtr:companyName><gtr:description>This company was set up to exploit the neuroprotective properties of the &amp;quot;inert&amp;quot; gas xenon.</gtr:description><gtr:id>AF8E5A0D-BCA5-4F5C-9626-7F02A377294A</gtr:id><gtr:impact>The discovery that xenon has neuroprotective properties has stimulated interest in the neuroprotective properties of noble gases and over 100 publications have results. Also several clinical trials have been initiated, one with MRC support. This company seeks to raise funds to carry out phase III trials but has only recently been formed so no impacts yet.

NB the URL given below is not active at the time of this submission but should soon be.</gtr:impact><gtr:url>http://neuroprotexeon.com</gtr:url><gtr:yearCompanyFormed>2014</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/46ACE3A8-B4B1-4C12-97EE-A7D2BAB8D78B"><gtr:id>46ACE3A8-B4B1-4C12-97EE-A7D2BAB8D78B</gtr:id><gtr:title>Copper block of extrasynaptic GABAA receptors in the mature cerebellum and striatum.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a04ba9acca2a866fd5378519b6734b55"><gtr:id>a04ba9acca2a866fd5378519b6734b55</gtr:id><gtr:otherNames>McGee TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B069F4D5-EF8D-47AE-9858-35D57FBE7BC5"><gtr:id>B069F4D5-EF8D-47AE-9858-35D57FBE7BC5</gtr:id><gtr:title>Neuronal ensembles sufficient for recovery sleep and the sedative actions of a2 adrenergic agonists.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0355658aee7a567caa922e6adbda88b6"><gtr:id>0355658aee7a567caa922e6adbda88b6</gtr:id><gtr:otherNames>Zhang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3AFFAAC7-6D32-48B8-BAA4-26523C8D8A21"><gtr:id>3AFFAAC7-6D32-48B8-BAA4-26523C8D8A21</gtr:id><gtr:title>Circadian factor BMAL1 in histaminergic neurons regulates sleep architecture.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1879cf77e5158dd3c9b1fb0724cc2274"><gtr:id>1879cf77e5158dd3c9b1fb0724cc2274</gtr:id><gtr:otherNames>Yu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6CD1F5E1-9427-474C-A46A-792A1B5B31B6"><gtr:id>6CD1F5E1-9427-474C-A46A-792A1B5B31B6</gtr:id><gtr:title>The role of K2p channels in anaesthesia and sleep.</gtr:title><gtr:parentPublicationTitle>Pflugers Archiv : European journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fc4a6734588d9a5f972897c64738d71b"><gtr:id>fc4a6734588d9a5f972897c64738d71b</gtr:id><gtr:otherNames>Steinberg EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0031-6768</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/499BC43C-666A-4A7F-8126-98FB9A17F47D"><gtr:id>499BC43C-666A-4A7F-8126-98FB9A17F47D</gtr:id><gtr:title>Molecular modeling of a tandem two pore domain potassium channel reveals a putative binding site for general anesthetics.</gtr:title><gtr:parentPublicationTitle>ACS chemical neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ffbe4ee5554c1a8980cde9e8ef56b7c5"><gtr:id>ffbe4ee5554c1a8980cde9e8ef56b7c5</gtr:id><gtr:otherNames>Bertaccini EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1948-7193</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/83136364-CC8B-4C45-9CE8-609F543B15C2"><gtr:id>83136364-CC8B-4C45-9CE8-609F543B15C2</gtr:id><gtr:title>Staying awake--a genetic region that hinders a2 adrenergic receptor agonist-induced sleep.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0530e1852c351609e066946ac4400ce8"><gtr:id>0530e1852c351609e066946ac4400ce8</gtr:id><gtr:otherNames>Gelegen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A6265165-9501-42D5-A2A6-E1A7FFD8C4E9"><gtr:id>A6265165-9501-42D5-A2A6-E1A7FFD8C4E9</gtr:id><gtr:title>Are extrasynaptic GABAA receptors important targets for sedative/hypnotic drugs?</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3edee91a0b5b4fed9a9168a8023d780d"><gtr:id>3edee91a0b5b4fed9a9168a8023d780d</gtr:id><gtr:otherNames>Houston CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB0CC662-8985-465E-838E-10616909BE62"><gtr:id>EB0CC662-8985-465E-838E-10616909BE62</gtr:id><gtr:title>A propofol binding site on mammalian GABAA receptors identified by photolabeling.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a6c14fc2adcbd78af89e4f76600cfba8"><gtr:id>a6c14fc2adcbd78af89e4f76600cfba8</gtr:id><gtr:otherNames>Yip GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E09DE0B3-935D-4804-A2A8-A6E5302E3C54"><gtr:id>E09DE0B3-935D-4804-A2A8-A6E5302E3C54</gtr:id><gtr:title>Activation and modulation of recombinant glycine and GABAA receptors by 4-halogenated analogues of propofol.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a59271a987962afd32b4dcc177d3c218"><gtr:id>a59271a987962afd32b4dcc177d3c218</gtr:id><gtr:otherNames>Germann AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CAD32F07-0296-42D1-A1C9-70B6C0659281"><gtr:id>CAD32F07-0296-42D1-A1C9-70B6C0659281</gtr:id><gtr:title>Structural comparisons of ligand-gated ion channels in open, closed, and desensitized states identify a novel propofol-binding site on mammalian ?-aminobutyric acid type A receptors.</gtr:title><gtr:parentPublicationTitle>Anesthesiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5242ed5d9484448933d16e182a2da433"><gtr:id>5242ed5d9484448933d16e182a2da433</gtr:id><gtr:otherNames>Franks NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-3022</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1068A0FD-044B-47C2-8EC7-2EB273F2E023"><gtr:id>1068A0FD-044B-47C2-8EC7-2EB273F2E023</gtr:id><gtr:title>Altered activity in the central medial thalamus precedes changes in the neocortex during transitions into both sleep and propofol anesthesia.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8960949b7145d41cb88c41c76118195"><gtr:id>d8960949b7145d41cb88c41c76118195</gtr:id><gtr:otherNames>Baker R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/04085A15-59F9-40CD-9BD2-642ADA93C981"><gtr:id>04085A15-59F9-40CD-9BD2-642ADA93C981</gtr:id><gtr:title>GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/838b7b52121a0eeeec8709ae049f60cb"><gtr:id>838b7b52121a0eeeec8709ae049f60cb</gtr:id><gtr:otherNames>Zecharia AY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1012F29B-48A1-4CA9-B63B-4050F76E42D2"><gtr:id>1012F29B-48A1-4CA9-B63B-4050F76E42D2</gtr:id><gtr:title>Mutational Analysis of the Putative High-Affinity Propofol Binding Site in Human ?3 Homomeric GABAA Receptors.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/51522d60aa1e3fd1e62bfbdafc976bb7"><gtr:id>51522d60aa1e3fd1e62bfbdafc976bb7</gtr:id><gtr:otherNames>Eaton MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43896C73-7405-45B1-8295-BF352112571C"><gtr:id>43896C73-7405-45B1-8295-BF352112571C</gtr:id><gtr:title>Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/45a922b9ee311c37b0f9857c7e0e290d"><gtr:id>45a922b9ee311c37b0f9857c7e0e290d</gtr:id><gtr:otherNames>Brickley SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0C3B37B0-BD00-4F96-83F8-EF261E6808B2"><gtr:id>0C3B37B0-BD00-4F96-83F8-EF261E6808B2</gtr:id><gtr:title>Bottom-Up versus Top-Down Induction of Sleep by Zolpidem Acting on Histaminergic and Neocortex Neurons.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/29150309c1083eefbbfc5576c662e95a"><gtr:id>29150309c1083eefbbfc5576c662e95a</gtr:id><gtr:otherNames>Uygun DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/818B1E74-F264-40A4-88D0-188A3229EFB5"><gtr:id>818B1E74-F264-40A4-88D0-188A3229EFB5</gtr:id><gtr:title>Identification of two mutations (F758W and F758Y) in the N-methyl-D-aspartate receptor glycine-binding site that selectively prevent competitive inhibition by xenon without affecting glycine binding.</gtr:title><gtr:parentPublicationTitle>Anesthesiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6723a628ec2e4c0c297cea48511b1e94"><gtr:id>6723a628ec2e4c0c297cea48511b1e94</gtr:id><gtr:otherNames>Armstrong SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-3022</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6E475981-A329-4305-85D0-83B8C948CB94"><gtr:id>6E475981-A329-4305-85D0-83B8C948CB94</gtr:id><gtr:title>Xenon neuroprotection in experimental stroke: interactions with hypothermia and intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Anesthesiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2a4bbdb875c190efb1fc6e86f72f4bca"><gtr:id>2a4bbdb875c190efb1fc6e86f72f4bca</gtr:id><gtr:otherNames>Sheng SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-3022</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1D250BF9-DBAE-41E0-A0E4-05D611930EDB"><gtr:id>1D250BF9-DBAE-41E0-A0E4-05D611930EDB</gtr:id><gtr:title>Wakefulness Is Governed by GABA and Histamine Cotransmission.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1879cf77e5158dd3c9b1fb0724cc2274"><gtr:id>1879cf77e5158dd3c9b1fb0724cc2274</gtr:id><gtr:otherNames>Yu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901892</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>